홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Hydroxide → Efinaconazole

HRID 53663
인쇄

반응식

HRID 53663 반응식
C1(C)C=CC(S([O:10][C@@:11]([C:27]2[CH:32]=[CH:31][C:30]([F:33])=[CH:29][C:28]=2[F:34])([C@H:18]([N:20]2[CH2:25][CH2:24][C:23](=[CH2:26])[CH2:22][CH2:21]2)[CH3:19])[CH2:12][N:13]2[CH:17]=[N:16][CH:15]=[N:14]2)(=O)=O)=CC=1.[OH-].[Na+]>C(OCC)C>[F:34][C:28]1[CH:29]=[C:30]([F:33])[CH:31]=[CH:32][C:27]=1[C@:11]([OH:10])([C@H:18]([N:20]1[CH2:25][CH2:24][C:23](=[CH2:26])[CH2:22][CH2:21]1)[CH3:19])[CH2:12][N:13]1[CH:17]=[N:16][CH:15]=[N:14]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 14798Sodium HydroxideHCID 88342129(2R, 3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidino)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol p-toluenesulfonate

생성물 1

HCID 489181Efinaconazole수율 74.3%

시약·촉매·용매 1

HCID 3283Diethyl Ether용매

실험 절차

To 18.3 g of the p-toluenesulfonate obtained above there were added 40 ml of ethyl ether and 35 ml of 1N aqueous solution of sodium hydroxide. The organic phase was taken out, and dried over 5 g of anhydrous magnesium sulfate and then the solvent was removed. There was added 40 ml of n-hexane to the residual liquid, and the precipitated crystal was separated by filtration, and dried to obtain 9.43 g of the desired (2R,3R)-2-(2,4-difluorophenyl)-3-(4-methylenepiperidine-1-yl)-1-(1H-1,2,4-triazole-1-yl)butane-2-ol. 1H-NMR spectrum of this compound coincided with that of the compound in Example 1.

후처리

  1. dry with materialdried over 5 g of anhydrous magnesium sulfate
  2. customthe solvent was removed
  3. additionThere was added 40 ml of n-hexane to the residual liquid
  4. customthe precipitated crystal was separated by filtration
  5. customdried

출처 및 근거

ORD 기록
ord-95f26bcfff1f42f7ba8d95bf590a9d25
출처 데이터셋
uspto-grants-1997_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US05620994

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트